It is often alleged that Canada's publicly-funded, single payer health care system, delivers better health outcomes, and distributes health resources more fairly than the mainly private U.S. multi-payer system. Our findings contradict these allegations. Differences between the U.S. and Canada in infant mortality and life expectancy -the two indicators most commonly used as evidence of better health outcomes in Canada-cannot be attributed to differences in the effectiveness of the two health care systems because they are strongly influenced by differences in cultural and behavioral factors such as the relatively high U.S. incidence of obesity and of accidents and homicides. Moreover, direct measures of the effectiveness of medical care, show that five-year relative survival rates for individuals diagnosed with various types of cancer are higher in the U.S. than in Canada as are infant survival rates of low-birth weight babies. These successes are consistent with the greater U.S. availability of high level technology, higher rates of screening for cancers, and higher treatment rates of the chronically ill. The need to ration when care is delivered "free" ultimately leads to long waits. Waiting times for medical services are a major problem in Canada and a source of unmet needs. In the U.S. costs are more often cited as a source of unmet needs. Nonetheless, with respect to the issue of inequality, we find that the health-income gradient is at least as prominent in Canada as it is in the U.S. When asked about satisfaction with health services and the ranking of the quality of services recently received, more U.S. residents than Canadians respond that they are fully satisfied and rank quality of care as excellent.
INTRODUCTION AND SUMMARY
The health care systems of the U.S. and Canada are very different. Canada has a single-payer, publicly funded system; the U.S. has a multi-payer, heavily private system. Critics of the U.S. health care system frequently observe that despite spending twice as much per capita on health expenditures as Canada, 15 percent of Americans lack health insurance and the U.S. performs less well on two commonly cited health outcome measures-infant mortality and life expectancy. In discussion of health care reform those observations are often used to support the view that Canada's single payer system should serve as a model for the U.S. 1 In this paper we focus on three questions: (1) How does health status differ between the two countries and what evidence is there that any observed differences are due to differences in health care systems? (2) How does availability and access to needed health care resources differ between the two countries? (3) Does the health/income gradient differ between the two countries?
We address these issues using data from the Joint Canada/ U.S. Survey of Health (JCUSH), a survey that was designed and conducted jointly by Statistics Canada and the U.S. National Center for Health Statistics. It is unique in that representative samples of U.S. and Canadian residents were asked the same set of questions under similar conditions, reducing concerns of comparability between the two countries, an issue that frequently arises in cross country comparisons. We supplement our findings from JCUSH with analysis of data from other Canadian and U.S. surveys and various national and international sources.
In brief we find that differences between the two countries in infant mortality rates and life expectancy cannot be attributed to differences in the health care systems. The infant mortality differential is due to the larger proportion of births in the U.S. that are at high mortality risk-in particular, low-birthweight births. The incidence of low birthweight appears to be linked largely to personal characteristics, not to the extent or quality of prenatal care. However, the quality of medical care does affect the chance that a low-birthweight infant survives. In that respect the U.S. appears to perform better than Canada. Survival rates of lowbirthweight babies are higher in the U.S. than in Canada, most likely because of greater availability of intensive neo-natal care facilities.
Among adults, mortality differences between Canada and the U.S. are largely attributable to life style and personal characteristics. For example, deaths from accidents and homicides explain most of the mortality difference among young adults and we estimate that they account for 25 percent of the differential in male life expectancy at age 20. Obesity increasingly has been linked to disease and mortality. The prevalence of obesity is substantially greater in the U.S. than in Canada and we estimate that the obesity differential can account for at least half of the difference in life expectancy at age 40 for both women and men. 2 Current health status is difficult to measure and interpret. On a number of self-reported measures of health status-overall level of health and the incidence of depression and pain-data from JCUSH and other surveys indicate similar health status in both countries. Based on information from the JCUSH, we find that Americans are more likely than Canadians to report having a chronic condition. But among those with a chronic condition, Americans are more likely to receive treatment for their condition.
With respect to resources devoted to diagnosing and preventing disease we find that the proportion of adults screened for cancers is higher in the U.S. as is the availability of technological scanners per capita (MRI and CT scanners) . The proportion of children immunized in both countries is about the same for older vaccines (e.g, DPT) but considerably higher in the U.S. for newer vaccines (e.g., varicella and PCV).
Waiting time for many medical procedures is considerably longer in Canada than in the U.S. Differences in screening and wait times may help to explain why 5-year relative survival rates among persons diagnosed with various types of cancer are higher in the U.S. than in Canada.
Regarding the seemingly universal tendency for health status to rise with income, we find that the health-income gradient is at least as steep in Canada as in the U.S.
Lastly, on two questions asked about satisfaction with health care and the ranking of quality of services received, a larger percentage of Americans than Canadians answered fully satisfied to the first and excellent to the second. We start our study by reviewing background information on the Canadian system. We compare the major characteristics of both systems and discuss how differences in the two systems might lead to differences in the quality of care and access to treatment. We then examine the traditional measures of a nation's health status-infant mortality and life expectancy-before turning to our analysis of health status differences using data from the JCUSH and other surveys. Resources are bound to affect the quality of care and we briefly compare those in Canada and the U.S. Finally we analyze and compare the relation between income and health status in the two countries.
BACKGROUND ON THE CANADIAN AND U.S. HEALTH CARE SYSTEMS
Canada provides public funding to cover medically necessary health care for all citizens and permanent residents, free of charge. But as a strict single payer system, it prohibits physicians from providing basic medical care for a fee and prohibits the sale of private insurance to cover its core services.
3 Some services such as dental and optometric care, physical therapy and prescription drugs are excluded from coverage by the national plan and are funded either out-of-pocket, by private insurance or in some instances, through benefit plans offered by the provinces.
The Canadian system is managed and administered by the provinces which receive partial funding from the federal government through an annual transfer payment. The provinces are then responsible for determining and financing their own health budgets, supplementing the federal contribution with their own taxes and other revenues. Although hospitals in Canada are mainly private non-profit and physicians are mostly private practitioners operating on a fee for service basis, the terms of their reimbursements are controlled and administered by the provinces in negotiation with provider associations. Initially, physician cost controls took the form of setting fees for various services. But it soon became apparent that increases in services could offset fee controls and so the provinces began to control total physician expenditures by setting caps on the overall incomes physicians could earn in their practices. 4 Some provinces also moved to control the supply of physicians through restrictive hiring practices and reductions in the number of first year students in medical school (Barer, Lomas, and Sanmartin, 1996) .
Over the years, fiscal pressures led to more stringent cost controls generating shortages and queues for services. The condition for shortages was enhanced by a provision in the 1984 Canadian Health Act which decreed that any service that the public system provides, no matter how much in short supply it may be, cannot be privately insured or produced and sold in Canada. 4 Provincial governments develop fee schedules and set up physician funding pools. If a pool goes over budget, "claw-back clauses" are enforced to ratchet down pay or doctors may be urged to close for a few days. Hospitals meet cost cutting by closing down hospital beds. See MacKenzie, 1999. instances death and concluded that: "the right to life and to personal inviolability is therefore affected by the waiting times."
5 The Court also ruled that the government's argument-that allowing a private sector would undermine the public system-was not supported by the actual experiences of many other countries such as the U.K., France and Germany that had moved to allow a private alternative to their public system. Some legal experts have concluded that the Chaoulli decision does not require the government to give up its single payer system as long as it reduces wait times for serious medical procedures to a reasonable length. In practice the decision seems to have led to an increase in private facilities providing core services, even outside Quebec, with the expectation that the government will not prosecute in light of the Chaoulli decision (Krauss, NY Times, 2006) . To some observers Canada is on its way to becoming a two-tier system. But there are no hard statistics on the extent of growth in private facilities and the situation is as yet unresolved. 6 The Chauolli decision was achieved by a thin majority in Quebec province and it is not known how the courts will rule for other provinces.
The major features of the U.S. health care system contrast sharply with those of Canada. The most important one is the generally greater role played by private markets in the U.S. That role is most important for the population under age 65, for whom the major source of funding for physician and hospital services comes from private insurance or out-of-pocket spending by individuals. Rates of reimbursement in this sector are largely determined by market forces involving private insurance companies interacting with physicians, hospitals and private individuals.
The U.S. Medicare program covers most of the population 65 and older. Premiums are charged for some services as well as deductibles and co-payments. Low income seniors, however, can obtain free health care through the Medicaid program. Medicare is federally financed and administered; the U.S. Congress and the President (through the executive agencies) determine benefits and financing. Faced with the problem of rising Medicare expenditures, the U.S. has also turned to regulation of provider fees. However, unlike Canada it has not attempted to control physicians' incomes. Physicians for example can increase procedures to offset fee controls or can refuse to serve Medicare patients and operate wholly outside of the system. The use of politically administered fees to control costs is likely to be inefficient in either country. Without market signals there is no good way to determine the appropriate payment for the myriad possible procedures and geographic locations. Medicare has moved towards greater utilization of private markets in recent years by allowing private insurers to offer plans to Medicare recipients that are financed by the government on a capitation basis but are privately administered.
Another important difference between the systems of the two countries relates to access to health care resources by the low income population. In the U.S., Medicaid, a large publicly funded and administered program, provides full coverage to a portion of the low-income population-poor single parent families, the disabled poor, the elderly poor. Like Medicare, it differs from the Canadian system in that it cannot regulate the total income physicians receive from the program or prevent a doctor from working outside the system.
In contrast to Canada, about 15 percent of the population in the U.S. is without public or private insurance. Medical care is available to the lower income uninsured population, though inconsistently, from government sponsored clinics and other programs.
7 However, as noted below, a portion of the uninsured has income sufficient to purchase private insurance and can be viewed as voluntarily choosing to self-insure.
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In Canada, private-sector spending on health now makes up about 30 percent of total health expenditures, a relatively high proportion private among the OECD countries. Canada spends much less of its GDP on health expenditures than the United States (10.4% in 2005 compared to 16 percent in the U.S.). Public funding of health expenditures has grown in the U.S. and now pays for more than 45 percent of the nation's health bill.
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When services are universal and provided free of charge, the problem of controlling health expenditures becomes a huge issue. Taxes cannot be raised indefinitely to pay for the unrestrained demands of the public. Various rationing strategies inevitably must be employed. Those politically determined decisions are likely to be inefficient and could have a significant effect on the nature of medical care. Problems of cost control also arise in the U.S., primarily in its publicly funded programs-Medicare and Medicaid. However, the U.S. has a large private sector in which market mechanisms can guide the allocation of resources and potentially produce more efficient results.
From the foregoing it is difficult to predict how well the two systems would perform in a comparison of the costs and benefits of their health care 7 Hospitals and physicians provide charitable care, the cost of which is covered by special reimbursements provided by state governments who obtain the funds from taxes on private insurance. Private hospitals are required (as a condition of their license to operate) to provide services to uninsured patients referred to them by clinics for treatment. 8 See footnote 10 below. 9 The U.S. is second to lowest in the public share of health expenditures among the OECD countries. (The OECD average is 73 percent.) Luxembourg-the second highest after the U.S. in health expenditures per capita-has the highest share of public funding (91percent).
systems. The U.S. spends much more on health care and therefore could be expected to be better endowed with new and expensive technology and a greater supply of highly skilled and specialized human capital. Incentives in private markets are likely to encourage the development of new treatment modes along with their more rapid adoption. On the other hand, the U.S. may waste resources due to inefficiencies that arise from its complex mode of reimbursement under which hospitals and doctors deal with multiple insurers with different fee scales and rules.
On the issue of accessibility, about 25 million low income individuals in the U.S. lack health insurance for more than a year. Although public services are available in many places, uninsured individuals, on average, obtain less care than the insured.
10 Yet accessibility can be limited in other ways and in Canada, despite universal coverage, access is restricted by long waits to receive care, particularly for those who are less adroit at navigating the system.
One difficulty often overlooked in evaluating the performance of the two systems is the problem of accounting for the effect of country differences in cultural and socio-economic factors that influence health outcomes. Canada and the U.S. differ in many ways. It is much smaller in terms of population-only 10 percent the size of the U.S and in some respects it is more homogeneous.
11 And perhaps more importantly, the two countries differ substantially in personal habits that influence health status. We begin our empirical work with an analysis of the determinants of infant mortality and life expectancy, two outcome measures where these issues come to the fore.
TWO TRADITIONAL MEASURES OF SYSTEM PERFORMANCE AND THEIR DRAWBACKS
Infant mortality and life expectancy are the measures most frequently cited as evidence of the superiority of the Canadian health care system. Table 1 10 Although some 45 million people lack insurance in the U.S. many are young, healthy and have incomes three times the poverty threshold or more. They can be viewed as voluntarily uninsured. (These are the authors' estimates based on data from the Current Population Survey and the Medical Expenditure Panel Survey.) About 25 million who do not meet these conditions can be viewed as involuntarily uninsured. For analysis of the resources received by the uninsured see Hadley and Holohan ( 2003) who estimate that the average dollar amount of health care received by the uninsured is about half that of those with private insurance. 11 Canada has a smaller non-white population than the U.S .and their non-white population is dominated by Asian immigrants with relatively high education and income. Only 2 percent of the Canadian population is black. African Americans make up about 13 percent of the U.S. population and 15% of births. Hispanics are the largest group of immigrants in the U.S. and account for an increasing share of the highly diverse white population. summarizes recent data on those measures for the U.S. and Canada. As shown in the table, in 2004 the infant mortality rate in the U.S. was 6.8 (deaths per 1000 live births) and 5.3 in Canada-a differential of 1.5 deaths per 1000 births. However, the differential is sharply reduced to only 0.4 deaths per1000 births when the comparison with Canada is restricted to the white U.S. infant mortality rate of 5.7. 12 Canada does not publish mortality infant mortality data by race or ethnic origin. However, the Canadian population is predominantly white (see fn. 10 above). Their largest minority group is Asian, a group that in the U.S. has a lower infant mortality rate than either the Canadian rate or the white U.S. rate (The Asian infant mortality rate is 4.7 in the U.S.). mortality and life expectancy are influenced by many factors that are unrelated to the quality and accessibility of medical care. We discuss them in turn.
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Infant Mortality
It is well established that in developed countries low birthweight is the major risk factor for infant mortality. Although the distribution of births by birth weight has not changed significantly over the past several decades, infant mortality has declined substantially in both Canada and the U.S. to a large extent due to improvements in the care of low-birthweight infants (Cutler and Meara 2000; Congressional Budget Office (CBO) 1992; Kramer, Barros and Demisse, 2005, McCormick, 1995) . Advances in medical technology and increases in expenditures on intensive care units have proven to be effective in reducing the risk of death to these highly vulnerable newborns (Cutler and Meara 2000) . The somewhat higher infant mortality rate in the U.S. than in Canada is due to the larger proportion of U.S. infants that are born weighing very little and are therefore at high risk of death. But the chances of a low-birthweight baby surviving are better in the U.S. than in Canada. This is an important distinction because the medical care system can bring resources to bear on improving survival among high risk infants, but has been largely unsuccessful in reducing the incidence of low birthweight, a point to which we return below.
We provide evidence in Table 2 on the role of differences in the incidence of low birthweight in explaining the infant mortality differential between the U.S. and Canada. The analysis requires data for each country on the distribution of births by birthweight along with infant mortality rates within birthweight specific categories. We utilize data form Kramer et al (2005) which provides the necessary ingredients. 13 The data for 1997 (1995-97 in Canada) are displayed in Table 2 and confirm that the U.S. has disproportionately more low-weight births than Canada. For example in the U.S. 1.4% of births weighed less than 1500 grams compared to 0.9% in Canada. However, within birthweight specific categories, mortality rates in the U.S. are lower than Canada's in the three lowest birth rate categories where mortality rates are highest and the same or slightly higher in the two highest weight categories. The mortality rates in those low birthweight categories are extremely high. For example, the risk of death to infants weighing less than 1500 grams was 262 per 1000 in Canada and 247 per 1000 in the U.S. 13 We could not use current published data from both countries because while Canada provides data on the distribution of births by birthweight it does not provide mortality rates for birthweight categories. The U.S., which has an extremely well developed vital statistics system, routinely provides both distribution and birthweight specific mortality rates. More recent data on the distribution of births by birthweight consistently indicate a greater incidence of low birthweight and preterm births in the U.S. compared to Canada.
To answer the question of how much the U.S. infant mortality rate would decline if the U.S. had Canada's distribution of births by birthweight but kept its own birthweight specific mortality rates we construct standardized averages as shown in Table 2 . We find that the U.S. infant mortality rate would decline from 6.85 to 5.40, slightly lower than Canada's observed rate of 5.5, if the U.S. had the Canadian birthweight distribution. Similarly, if births in Canada were to have the same distribution by birthweight as U.S. births and retained the Canadian birthweight-specific mortality rates, the Canadian infant mortality rate would rise to 7.06 from their observed rate of 5.5. It is difficult to expand this analysis to other countries and other time periods because of the lack of data on birthweight specific mortality rates, which are not readily available for countries other than the U.S. A study by the Congressional Budget Office (1992) located such information for a few countries in the early 1980s. The CBO report shows that the U.S. had significantly lower birthweight specific mortality rates (for both white and black infants) compared to Japan and Norway even though total U.S. infant mortality rates (11.1 for whites and 19.8 for blacks) were higher than the total infant mortality rates in Japan and Norway (10.8 and 10.5 respectively). As in the comparison with Canada, it was the much higher proportion of American births weighing 1,500 grams or less that accounted for the higher total infant mortality rate in the U.S. despite the fact that the chance of survival was significantly greater in the U.S. in almost every birthweight specific category.
Sophisticated and costly medical care in intensive neonatal care units is needed to improve the survival rates of low-birthweight babies. Cutler and Meara (2000) ask the question "Is it worth it?" and conclude that the benefits, in terms of the value of quality adjusted life years gained, do indeed outweigh the high costs.
14 Some countries may conclude otherwise and limit the provision of neonatal units for high risk births. We have found no comprehensive analysis of access to specialized neonatal care units in Canada and the U.S. although recent news accounts suggest that Canada has fewer such facilities per capita than the U.S.
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14 Cutler and Meara (2000) show data by birthweight for the late 1980s indicating direct medical costs associated with hospital admission at birth until discharge ranging from $35,000 to $68,000 for birthweight less than 1000g, with declining costs at higher birthweights. The high costs are the result of the high daily rate in intensive neonatal care for high risk births and the long stay required. The Cutler/Meara cost /benefit analysis adds to these initial costs the additional lifetime education and medical costs of a low birthweight baby. Their estimated rate of return to increased spending on low-birthweight infants is more than 500%.
The next important question is whether the incidence of low birthweight is influenced by differences in quality and access to health care. Low birthweight occurs as a result of congenital anomalies, preterm birth or intrauterine growth restriction. The determinants of these conditions are not fully understood but have been found to be associated with a woman's personal characteristics-in particular, low levels of education and income, and with behavior while pregnant such as cigarette smoking, alcohol and drug use (Corman and Grossman, 1985; 1987; Joyce, Racine, McCalla and Wehbeh, 1995; Joyce and Grossman, 1990; Kaestner, Joyce and Wehbeh,, 1996; Kramer, 2003) .
Government efforts to improve birth outcomes by reducing financial barriers to prenatal care typically have not been successful. Improvement in access to health care for low income women through extension of Medicaid seems to have increased prenatal care but failed to reduce the gap in birth outcomes for poor and non-poor women (Dubay, Joyce, Kaestner et al., 2001; Currie and Gruber, 1996) . In Canada, despite universal coverage, universal uptake of prenatal care has not been realized. In a randomized trial in which pregnant women were offered supplementary prenatal care, retention proved to be a major problem. The unreachable women were "more likely to be single, use drugs, report distress and adverse life events", the very women one hopes to reach with prenatal care (Tough, Siever and Johnston, 2007) . Mustard and Roos (1994) examined the relationship of prenatal care and pregnancy complications to birthweight in Winnipeg and found that women in the poorest income quintile had lower utilization rates of prenatal care than wealthier women and gave birth to lower birthweight infants. However, the lower utilization of prenatal care accounted for little of the difference in birthweight, which was largely attributed to behavioral factors not directly influenced by prenatal care (such as smoking and unmarried status).
Efforts to reduce preterm birth through medical intervention have also met with little success. In a review article on prevention of premature birth, Goldenberg and Rouse (1998) conclude that "Most interventions designed to prevent preterm birth do not work, and the few that do, including treatment of urinary tract infection, cerclage, and treatment of bacterial vaginosis in high risk women, are not universally effective and are applicable to only a small percentage of women at risk for preterm birth." The recent report of the Institute of Medicine on preterm births reaches the same conclusion (IOM, 2007) .
Demographic factors appear to influence low-birthweight and infant mortality. It is often observed that babies born to teenage mothers are at particularly high risk of infant mortality due to a high prevalence of preterm, lowbirthweight births (W. Gilbert et al., 2004; Fraser et al., 1995) . The teenage birth rate in the U.S., despite a substantial decline since the early 1990s, is the highest among comparable countries (United Nations Statistics Division, 2004) . Infants born to mothers under age 20 accounted for 10.3% of all births in the U.S. in 2004, but only 4.2% of all births in Canada. The infant mortality rate of babies born to mothers under age 20 in the U.S. was 9.75 per1000 live births-50% higher than the infant death rate of babies born to mothers age 20 and older. 16 Several explanations have been given for the association between adverse birth outcomes and adolescent motherhood. Some studies conclude that young maternal age is not an independent risk factor and reflects socioeconomic factors related to teen pregnancy such as race, poverty, being unmarried (Yoder, 1997; Rogers, 1995) . Others find an intrinsic physiological reason for the association. Utilizing a data set with extensive information on birth outcomes and the medical and socio-economic characteristics of pregnant women over the period -2000 , Chen, Wen, Fleming et al. (2007 find that "teenage pregnancy increases the risk of adverse birth outcomes that is independent of important known confounders." They note that immaturity of the uterine or cervical blood supply could increase the risk of infection and prostaglandin production and lead to increased risk of a pre-term delivery. In addition, pregnant teenagers who have not completed their own growth may compete with the growing fetus for nutrients. It is likely that the high teen birth rate in the U.S. contributes to the relatively high incidence of low birth weights and therefore to the higher U.S. infant mortality rate, although the size of the contribution is difficult to measure.
Two developments that have affected infant mortality are worth noting. One is an increase in preterm and low-birthweight births in Canada and the U.S. due to an increase in assisted reproduction technologies which often give rise to multiple births (Blondel, Kogan et al. 2002) . Another is the use of abortion to terminate pregnancies when the fetus is found to have congenital anomalies, a practice that reduced infant mortality in Canada in the mid 90's. Liu, Joseph et al., 2002 , found that after fluctuating between 6.4 and 6.1 per1000 live births between 1991 and 1995, the Canadian infant mortality rate dropped sharply to 5.4 in 1996 and 5.5 in 1997. At the same time, fetal deaths due to termination of fetuses with anomalies increased. Provinces with higher rates of fetal death due to terminations had lower rates of infant deaths due to congenital anomalies. We have found no comparable study for the U.S. 17 The extent to which differences in the incidence of multiple births or selective termination of pregnancies currently contribute to the infant mortality differential between Canada and the U.S. cannot be determined.
There is much that remains unknown about the determinants of infant mortality. Within the U.S. the infant mortality rate of both blacks and whites has declined over time but the black infant mortality rate of American born blacks remains more than twice the rate for whites. The relatively high incidence of low birthweight among blacks explains much of the black-white difference in mortality, but the extent to which the difference can be explained by socioeconomic or genetic factors is not at all clear. Infants of African-born black women have been found to have birth-weights and birth outcomes close to those of white infants and quite different from those of American-born black women (David and Collins, 1997) . Another anomaly is the relatively low infant mortality rate of Hispanic babies in the U.S., a rate that is the same or lower (in the case of Cuban and Mexican babies) than that of white non-Hispanics (Hummer et al., 2007) . Yet Hispanics have a relatively high incidence of poverty and are much more likely to lack health insurance than other groups.
Life Expectancy and Adult Mortality
Life expectancy, like infant mortality, is an inadequate and misleading measure of a country's quality of health care. Life expectancy measured at birth is influenced by infant mortality and at older ages the overall mortality rates do not delineate between causes of death susceptible to improved medical treatment and those that are not. Included in the latter are deaths from homicide, auto and other accidents and deaths related to personal characteristics such as smoking, obesity and lack of physical activity. The U.S. population is more prone than the Canadian to die in accidents and homicides and to engage in habits leading to obesity and the adverse health outcomes that result. In this section we estimate the extent to which the country differences in mortality and life expectancy can be explained by differences in behaviors such as homicides and accidents and obesity. Table 3 displays mortality rates by 5-year age group and by sex in Canada and the U.S. along with causes of the age-sex specific mortality differentials. Although the overall mortality rate is higher in the U.S. at all age levels, the importance of non-disease related factors (accidents and homicides) is much greater in the U.S. Among men, accidents and homicides account for 84% of the absolute gap in mortality rates at age group 20-24. The share explained by accidents and homicides declines as age increases, but still accounts for close to 30% of the gap at ages 40-44.
In relative terms (as a percent of the average death rate at each age) the total gap in mortality rates declines quite sharply with age after age 44-among men, from 50.9% at ages 40-44 to only 13% at ages 70-74. (This measure of the relative gap is shown in column 4 of Table 3 .) Among women the relative gap declines from 57% at ages 40-44 to 23% at ages 70-74. Thus the differentials in accident and homicide death rates surely account for a significant part of the differential in life expectancy which in 2002 for a 20-year old male was 57.7 years in Canada and 55.6 years in the U.S. Using the mortality data in Table 3 we made a rough estimate of the extent to which the life expectancy difference can be explained by accident and homicide related deaths. For each age group in Table 3 we reduced the annual U.S. mortality rate by the excess of the U.S. rate for accidents and homicides over the Canadian rate. Thus for the 20-24 year old male group we lowered the average annual mortality rate per 100,000 from 138 to 91. (=138 -55.6 x 0.844); the 25-29 group from 136 to 94 and so on up to the 70-74 group for which the rate of 3279 was reduced to 3266. We then estimated the life expectancy of a 20 year old male in the U.S. using these modified annual death rates.
Our rough estimate raises life expectancy for a 20 year old male by 0.5 year. As reported in the vital statistics of each country, the life expectancy of a 20 year old male is 2.1 years higher in Canada than in the U.S. Thus the difference in homicide and accident rates could explain as much as 25 percent of the 2.1 year gap in male life expectancy at age 20.
In recent years a growing literature has documented a significant effect of obesity on disease and mortality along with a growing incidence of obesity in both the Canadian and U.S. populations. 18 The U.S., however, leads the advanced countries in the incidence of obesity (OECD 2007) . 19 Among the female population in the U.S. 33.2% are reported to be obese compared to 19% in Canada, and similar differentials prevail for men (U.S., 31%, Canada, 17%).
To what extent does the difference in the prevalence of obesity between Canada and the U.S. account for the life expectancy differential? As shown in Table 3 , as age increases cardiovascular disease becomes an increasing source of the differential in mortality rates between Canada and the U.S. Cardiovascular disease is one cause of death attributed to obesity about which there is considerable consensus. 20 We provide rough estimates of the possible effect of the obesity differential on life expectancy using the results of a study by Peeters et al. (2003) which specifically addresses the effects of obesity on life expectancy.
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The study utilizes the long-run longitudinal data collected for the Framingham Heart Study with follow-up on mortality.
The Peeters et al. sample consisted of about 3,500 participants who were ages 30-49 at baseline in 1950 and were followed up for more than 40 years. Age of death was recorded along with detailed data on the participants' height and weight in 1950, as well as on many other determinants of health and longevity including smoking. A statistical analysis provided estimates of the net effect of obesity on longevity, separately by gender and smoking habit. Column 2 of Table  4 contains the findings of the Peeters study on the years of life lost by a 40 year old obese individual (an individual with a body mass index of 30 or more). We show the data separately for men and women giving average values for smokers and non-smokers. The expected years of life lost at age 40 are 6.2 for men and 7.1 for women. We assume that the net effect of obesity on life expectancy would be the same in Canada and the U.S. Table 4 provides the ingredients for our estimate of the reduction in expected years of life at age 40 due to obesity in Canada and the U.S. Column 1 shows life expectancy at age 40 in Canada and the U.S. as shown in each country's life tables, separately by sex. Column 2 as noted gives the estimates derived from Peeters et al. of years of life lost by an obese person. Column 3 shows the percentage of men and of women who are obese in Canada and in the U.S. To estimate the reduction in expected years of life remaining at age 40 we multiply the years lost by an obese person by the percent obese in each country. The results, shown in column 4 of Table 4 indicate that the higher percent obese in the U.S. reduces the life expectancy of male 40 year-olds by 2.1 years in the U.S. and by 1.2 years in Canada-a differential reduction of 0.87. The reduction in life expectancy for 40-year old women is 2.6 years in the U.S. and 1.5 years in Canada-a differential reduction of 1.07. Comparing the differential reduction in life expectancy due to obesity with the observed difference in life expectancy at age 40 (column 1) we find that the obesity difference accounts for 54 percent of the male life expectancy gap and 63 percent of the female life expectancy gap. The remaining differential in life expectancy at age 40 after adjusting for obesity alone is therefore 0.7 years for men and 0.6 years for women. 20 Studies have not been in agreement on the effect of obesity on deaths from cancer but there seems to be a consensus on the finding of a significant effect of obesity on deaths attributable to cardiovascular disease (Flegal et al. 2007, Malnick and Knobler, 2006) . 21 Torrey and Haub (2004) estimate excess US deaths relative to Canada in 1998 by age, sex and cause and also estimate the extent to which the differential in life expectancy can be attributed to obesity.
Our estimates of the effect of obesity are intended to be illustrative. Obesity is difficult to measure. 22 To minimize error we used measures of obesity from each country's own survey based on clinical measurement of height and weight for men and women by age. Our estimates are obviously sensitive to the measure of years of life lost by an obese individual (for which we use results based on the Framingham study) as well as to the assumption that the net effect of obesity on life expectancy would be the same in the U.S. and Canada. As more Peeters et al. (2003) . Peeters et al. find that 40 year old female non-smokers lost 7.1 years due to obesity (little difference for smokers); obese male smokers lost 6.7 years and obese male non-smokers lost 5.8 years. We use an average of 6.2 years to derive the reduction in years lost due to obesity for men. We assume that the loss in years due to obesity would be the same in Canada and the U.S. and multiply the percent obese in each country (by sex) times the relevant gender specific number of years lost from the Peeters study.
22 See fn. 19 above for additional detail.
long-term longitudinal studies of the direct link between obesity and life expectancy become available it will be possible to assess the validity of these assumptions. Our estimates do not adjust for degree of obesity and physical fitness activity, both of which are likely to affect the results. On that score Americans are more concentrated in the highest level of obesity than Canadians and are more likely to be inactive. 
OTHER MEASURES OF HEALTH STATUS
Our analysis of the widely used differentials in life expectancy and infant mortality suggests that the U.S.-Canada differentials in those measures of health status are not likely to be due to differences in the health care systems of Canada and the U.S. We continue our search for evidence of health outcome differentials that might be attributed to the effectiveness of the two systems. We utilize the various measures of health status available in the JCUSH data as well as in other data sources.
JCUSH-the Joint Canada/U.S. Survey of Health-was conducted by means of a telephone survey of residents of the U.S. and Canada aged 18 and older living in private dwellings with telephones. The data were collected during the period November 2002-March 2003. Interviewers were trained and the survey was administered in English or Spanish to Americans and in English or French to Canadians as need dictated. The final samples include 3,505 Canadians and 5,183 from the U.S. The US samples were stratified by four regions; the Canadian sample by province. The Appendix presents the weighted characteristics of the samples for the two countries used in our analysis. Table 5 presents results from a survey question that asks individuals how they rate their overall level of health: poor, fair, good, very good and excellent. This is a widely used measure of health status in health research. One drawback of the measure is its highly subjective nature. If the frame of reference influencing the concept of good health differs significantly between two countries it may not be useful for answering the question whether one population is healthier than the other. Given that Canada and the U.S. are close geographically and similar culturally in some ways, this may not be a serious problem. We show results from JCUSH as well as from other major health surveys conducted in the U.S. and Canada which ask the same health status question.
In Table 5 we control for two non-system factors that affect health status-age and race. We use the 65+ age break here and throughout the paper because Medicare provides near universal coverage for that age group in the U.S., a factor that might change the relative standing of the countries when compared 23 JCUSH provides this information. See Appendix Table 1 for details on these measures. with results for the younger respondents. We show separate results for whites when available because non-whites are a larger proportion of the population in the U.S. (26% of the 18-64 year-olds in JCUSH for the US, 19% for Canada) and the composition of the non-white group differs by country-predominantly black in the U.S., but Asian in Canada. In the U.S., as noted, the black population is observed to have relatively poor health outcomes and the Asian population has better health outcomes than the white population.
The results in Table 5 show little difference in self-perceived health status between Canada and the U.S. In JCUSH, two-thirds of the white population ages 18-64 report very good or excellent health in both countries; about 9% report poor or fair health in both countries. Among all races at ages 18-64 the percent reporting very good or excellent health is somewhat higher in Canada and the percent reporting poor or fair health is somewhat higher in the U.S. The results differ somewhat when the comparison is based on the Canadian Community Health Survey (CCHS) and U.S. National Health Interview Survey (NHIS) which cover the population ages 20-64. In that comparison the proportion reporting very good or excellent health is somewhat higher in the U.S. for all races as well as for whites only. At ages 65 and older the percent reporting very good or excellent health is lower in both countries as expected, but the U.S. has the advantage among all races as well as whites only for this age group in both the JCUSH and the CCHS/U.S. NHIS comparisons. Table 6 shows three additional and more detailed indicators of health status (all from JCUSH). The first measure is the individual's score on the Health Utility Index (HUI). The index, based on the Comprehensive Health Status Measurement System(CHSMS) developed at McMaster University, provides a description of an individual's overall functional health based on eight attributes: vision, hearing, speech, mobility (ability to get around), dexterity of hands and fingers, memory and thinking, emotion, and pain and discomfort. The HUI maps the responses into a scale ranging from negative to 1 (where one means perfect health and negative means worse than death). The HUI sequence of questions was administered to all respondents. The second measure refers to the probability of a major depression in the past year based on a set of questions from the Composite International Diagnostic Interview. The last measure is a response to a question whether the respondent has pain that prevents some or most activities.
For the 18-64 year old age group the results indicate little country difference on any of the three indicators, especially when the comparison is restricted to whites only. The differentials between the U.S. and Canada are about the same for the older group as for the younger group. But again we note that in comparison with the younger group the older group reports generally weaker health in both countries based on the lower HUI and the higher level of reported pain.
What can be concluded from these comparisons of health status? The results suggest that if there is a difference in health status it is not large enough to be noticed by the population. But the results, taken alone, still do not allow us to evaluate the comparative efficiency of the two health systems. 1) Major depression refers to those with 90 percent probability of depression. This variable calculates the probability that the respondent would have been diagnosed as having experienced a major depressive episode in the past 12 months, if they had completed the Long-Form Composite International Diagnostic Interview (CIDI). The items used to measure depression are a subset of items from the CIDI that measure major depressive episode (MDE). The short-form of MDE used in the JCUSH was developed to operationalize the diagnosis of MDE.
Note: None of the U.S.-Canadian differences are statistically significant.
Source: JCUSH micro data (weighted means).
PREVALENCE AND TREATMENT OF CHRONIC CONDITIONS
A basic problem in comparing the quality or effectiveness of medical care in the two countries is the difficulty of measuring the underlying health of the population and the extent to which observable health conditions are amenable to medical treatment. JCUSH provides individual reports on the incidence of significant chronic health conditions along with information on whether the individual was being treated for the condition and the results are given in Table 7 . Although the measures of chronic conditions are self reported, their specificity is likely to make them less subjective than rankings of overall health. Indeed, there is some evidence that self reported information on chronic conditions is reasonably accurate. Banks et al (2006) in a study of differences in the prevalence of chronic disease in the U.S. and England compare self reported survey results with direct clinical tests. The findings from both measures of prevalence are not identical but they are reasonably close and provide similar indications of country differences. Table 7 shows that the incidence of chronic diseases is higher in the U.S. for all of the conditions listed for the age group 18-64. (Banks et al also find that the U.S. has a higher level of chronic disease than England.) The prevalence of both high blood pressure and diabetes is notably higher in the U.S. (about 50% higher) suggesting a possible link to obesity which is known to be related to hypertension and diabetes. A higher U.S. prevalence of high blood pressure and diabetes is also observed at ages 65 and older although the relative differences are not as large. Among the older groups there are also some reversals-Canada for example has a higher incidence of angina and asthma. Table 7 also shows the percentage of those currently with a specific condition who are receiving treatment for it. On this indicator of access to care the U.S. performs better with respect to the treatment of most of the conditions enumerated and this is the case for both the younger and older groups.
In sum, the message of Table 7 is that the incidence of chronic disease is generally higher in the U.S., but the utilization of treatment for these conditions is somewhat greater in the U.S. We next turn to JCUSH and other data sources to investigate the availability and access to certain key health care services in the two countries.
RESOURCE AVAILABILITY: SCREENING, IMMUNIZATION, TECHNOLOGY AND WAITING
We cover the extent to which each country provides screening for various cancers, immunizes children against serious diseases and is endowed with technological devices for diagnostic purposes. We also report on waiting times for services. Table 8 shows utilization rates of preventive care services for adults by Canadians and Americans using JCUSH supplemented by data from the Canadian Community Health Survey (CCHS) and the U.S. Medical Expenditure Panel Survey (MEPS). Table 9 looks at childhood immunization rates. In Table 8 we look at mammography and PAP smears for women, at colonoscopy or sigmoidoscopy (CorS) for women and men, and the incidence of PSA testing for men in the two countries for relevant age groups. The table shows first, for each age group, the percent of women who at the time of the survey said they had ever had a mammogram or PAP smear. The table then distributes this same sub-group by how recently they had their last mammogram or PAP smear, but using the total number of women in the age group in the denominator. (The percent having the procedure more than 5 years ago is not shown.) The table clearly shows that these two significant cancer screening health services for women are used significantly less in Canada than in the U.S. About 86% of women in the U.S. (ages 40-69) had ever received a mammogram in the U.S. compared to 74% in Canada. Moreover, 74% of all women in the U.S. had received a mammogram within the past two years compared to only 57% of Canadian women. The findings from JCUSH are similar to those of the other health surveys shown. The difference in PSA testing for prostate cancer is also very large as is the difference in (CorS).
Cancer Screening and Child Immunization
Because screening for early detection of cancer has the potential to significantly reduce mortality from the disease, these differentials are bound to influence health outcomes produced by Canada and the U.S.
An array of vaccines is now available for preventing diseases that could cause death or produce serious health complications. As shown in Table 9 immunization rates for young children are high in both countries for the older vaccines. Thus the U.S. rate for combined DPT (diphtheria, pertusis and tetanus) is 86%. Canada appears to give these vaccines separately to about 75% of children. Immunization rates for MMR (measles, mumps and rubella) are 93% in the U.S., 94% in Canada. But immunization rates for the newer and more costly vaccines (varicella, hepatitis B and PCV) are considerably higher in the U.S. For instance, 73% of U.S. children receive the PCV vaccine (pneumococcal conjugate vaccine) compared to only 7% in Canada.
Screening Devices
Canada is far behind with respect to the availability of Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) Scanners. In 2004 the U.S. had 32 CTs per million population compared to Canada's 2005 endowment of 11.3 per million. The gap is even larger for MRIs-27.0 per million versus 5.5 per million.
24 Again, as with the differentials in screening, the huge gap in equipment has the potential to create differentials in health outcomes. On the other hand, if 24 The data cited here on the availability of CTs and MRIs come from the Canadian Institute for Health Information, Medical Imaging in Canada, 2005 . The data are comparable for the U.S. and Canada and include units located in hospital and non-hospital sites. such expensive equipment is inefficiently used in the U.S. it could contribute to the higher expenditures in the U.S. but have little effect on health outcomes as some critics suggest. 
Waiting Times and Unmet Needs
In the wake of the Chaoulli decision, wait times for various medical services in Canada have become an emotionally charged issue in Canada. In 2004, the Canadian First Ministers agreed to develop a 10-year plan to improve access and 25 In their study of the British health care system Aaron and Schwartz (2005) address the relatively low level of spending by the British on imaging machines, raising the question, "Sensible Savings or Foolish Frugality?" (pp.89).
reduce waiting times for a few key services including hip and knee replacement and cataract surgery. How widespread and how long are actual waiting times in Canada? And how do these waiting times compare with the U.S.? Statistics Canada has begun to collect survey data on wait times. In a 2005 report on accessing care they indicate that with respect to non-emergency surgeries, 60 % of individuals age 15 and older who reported waiting times (for services accessed in the past 12 months) said they had waited more than one month; 19% waited more than three months. For joint replacement and cataract surgery the waits were much longer-68% waited more than one month; 32% more than three months. To see a specialist, 54% waited more than one month, 13%, more than three months. To get a diagnostic test, 44% waited more than one month; 10 %more than three months (Statistics Canada, 2006) .
The issue of waiting time has not been prominent in the U.S. and is not routinely surveyed by the U.S. statistical agencies. The Canadian Institute for Health Information (2007) collected some information on waiting times from both Canada and the U.S. and reported considerably lower wait times in the U.S. to see a specialist or have elective surgery. Siciliani and Hurst (2003) examine waiting times for elective surgery in OECD countries and the reasons for them. Canada was one of 12 countries in which waiting times were viewed as a serious health policy issue. The U.S. was one of the countries with low wait times. The study found that waiting times are negatively associated with increases in physicians and specialists per capita and an increase in total health expenditures per capita. Fee-for-service remuneration for specialists as opposed to salaried remuneration is associated with shorter wait times. These findings are not surprising and suggest the trade-offs that are made to keep costs low when politically administered decision-making replaces market pricing.
The JCUSH data do not measure length of waiting spells but do present information on the incidence and significance of waiting to individuals in the two countries. The issue is addressed as part of a question about whether the respondent experienced unmet medical needs and if so, what the reason was for the unmet need. Among those ages 18-64, 14.4% of Americans and 11.3% of Canadians reported experiencing one or more unmet health care needs in the year prior to the survey (Table10). Among older people the percentages reporting unmet needs are about the same in the two countries. Those with an unmet need were then asked the reasons for the unmet need-long waiting period, service not available; cost; or a reason other than those two. (More than one reason could be given). As Table 10 shows, the wait-too-long/service-not-available reason dominates among Canadians who had an unmet need, while for U.S. residents cost was the major factor and wait-too-long was quite minor. Because more than one reason could be checked, the much higher proportion (56% versus 13%) citing waiting is additional confirmation of the waiting difference between the countries.
Clearly, waiting times are significantly longer in Canada than in the U.S. But does the extra waiting time have an important effect on well being? Using the JCUSH data we cross-classified individuals in each country who reported having an unmet need by the reason for the need and whether they reported suffering significant activity-limiting pain during the year We found that among those who gave "wait too long or not available" as reasons, 33% of Canadians said they had pain that limits their activities compared to 22% of the much smaller Table 10 Percent group of Americans in that category. Among those who gave "cost" as the reason for the unmet need, 29% of Americans reported pain compared to 37% of the smaller group of Canadians.
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Corroboration for the possibly harmful effects of waiting are reported by Statistics Canada which finds that of those who experienced long waits for specialist visits, non-emergency surgeries and diagnostic tests, a large majority cited worry, anxiety, and stress; about 40-55% cited pain. 27 Among those who waited for non-emergency services such as joint replacements, 36% reported having a problem with activities of daily living. Waiting, therefore, is more than just a nuisance and causes considerable distress to a large proportion of those who experience it. Waiting for a diagnostic test, for example, can produce serious anxiety regardless of the ultimate outcome of the test.
DIFFERENTIAL SYSTEM EFFECTIVENESS: EVIDENCE FROM CANCER AND HEART ATTACK SURVIVAL STUDIES
Based on our analysis of JCUSH and of other large health interview surveys in Canada and the U.S. we find that the U.S. makes much greater use of early detection testing (mammograms, pap tests, PSA tests and colonoscopies) and has a substantially larger endowment of medical imaging machines used for early detection (MRIs and Ct Scans). If those procedures and machines are impacting health outcomes we should observe it in data on mortality and survival rates for those who have cancer. Ideally one would want to know the results of broadly applicable studies of survival rates conducted under the same circumstances in both countries, but such studies are difficult to find. Table 11 provides national level data collected by cancer institutes in Canada and the U.S. on mortality rates and incidence rates for five types of cancer that could be affected by early detection tests as well as by treatment efficacy. Three-year averages are shown. The age adjusted cancer incidence rate is higher in the United States than in Canada for all of the types of cancer shown (except for colorectal cancer for men). The mortality rates are more mixed and the differences are smaller between the countries.
Among women, the ratio of mortality to incidence is somewhat lower in the U.S. for all cancers together and for three out of the four cancers shown (cervical cancer being the exception). Among men the story is similar, but the ratio is lower in the U.S. for all cancers shown. A possible inference of the table is that survival rates are higher in the U.S., although the U.S. population is more prone to develop the disease.
A more direct measure of the effectiveness of medical care is the cancer survival rate for those diagnosed with the disease. The cancer institutes of the U.S. and Canada estimate relative survival rates for the whole gamut of cancers. As shown in Table 12 , the age adjusted five-year relative survival rate for all cancers combined is higher in the U.S. For men, the survival rate is 65% in the U.S. and 58% in Canada. Among women, 65% in the U.S., 62% in Canada. Among the most prevalent types of cancer relative survival rates are higher in the Table 11 Incidence 2) Includes all types of cancer.
3) Canadian data excludes Ontario.
Source: Canadian Cancer Society/National Cancer Institute of Canada: Canadian Cancer Statistics 2007 , Toronto, Canada, 2007 National Cancer Institute, SEER Cancer Statistics Review 1975 U.S. for prostate, breast and colorectal cancer as well as for non-Hodgkin lymphoma and melanoma. Survival rates for bladder and lung cancer are about the same in both countries. Among the less common cancers, survival rates were higher in the U.S. for brain cancer, leukemia, multiple myeloma, cancer of the esophagus and ovarian cancer while rates were higher in Canada for cancer of the larynx, oral cavity and liver. Cancer survival rates are also higher in the U.S. than in European countries. The Eurocare-4 Working Group compared 5 year relative survival rates (age adjusted) from European registries of cases diagnosed in 2000-2002 with cases from the U.S. SEER registries also diagnosed in 2000 -2002 . (Verdecchia et al. and the Eurocare-4 Working group, 2007 . The weighted mean relative survival rate for all malignancies among men in the European registries was 47.3%, significantly lower than the 66.3% survival rate for American men.
28 (Sweden with a rate of 60.3% was the closest to the U.S. rate.) The differential was smaller for women-the European mean survival rate was 55.8% compared to the U.S. rate of 62.9%. (Sweden, Iceland, Finland, Belgium and Switzerland were close to the U.S with survival rates of 61.1-61.8).
Differences in medical outcomes are due to many factors including the training and skills of health practitioners, the use of evidence-based guidelines, investment in diagnostic and treatment facilities and also the medical condition of the patient. The higher medical expenditures in the U.S. may well be employed to produce the superior results suggested by these comparisons. With respect to medical outcomes for diseases other than cancer we note that patients with acute myocardial infarction have been found to survive longer in the U.S. over a fiveyear period than in Canada (Kaul, Armstrong et al., 2004) . This study attributed the better outcomes in the U.S. to its more aggressive therapy regime, in particular the much higher revascularization rates at an early stage. The negative effects on survival of Canada's more conservative practices were not observed in the shortterm but became evident over the 5-year period. Other studies have found similar differentials between the U.S. and Canada regarding the treatment and outcomes of cardiac patients in the two countries (Rouleau et al., 1993; Pilote et al., 1995) .
EVIDENCE ON THE DIFFERENCE IN THE INCOME-HEALTH GRADIENT
One of the benefits anticipated from a single payer system is a more equitable distribution of health resources and health outcomes than would occur in a system where access partly depends on ability to pay. We turn now to evidence on the claim that in Canada the relation between favorable health outcomes and income is minimal or is much less strong than in the U.S. In other words we investigate whether the income/health gradient is steeper in the U.S. than in Canada Although numerous studies have examined the relation between income and health, not many have related the degree of inequality in income of individuals to inequality in their health status within a given country. Some studies have looked broadly at the relation between health and income historically; and across and within countries (Cutler, Deaton and Lleras-Muney, 2005) . Many studies simply look at variation in mean income across areas (countries, states) and relate it to observed measures of health status (Marmot, 2002) . Other across-location studies relate measures of inequality of income (variation across areas) to variation in the average level of health across areas (Ross et al., 2000) .
Our interest, however, is in the correlation across individuals in their personal income and their personal health status, and in the comparison of this relationship in Canada and the U.S. The data demands of such a study are difficult to meet because of the difficulty of assembling data for different countries with similar measures of both income and health status. Data on the personal incomes of individuals and households are collected in both Canada and the U.S, as are some measures of health status (typically self reported health status). But the data on income are both measured and published in different formats making unbiased estimates in both countries difficult to execute. The main empirical problem in comparing gradients in the U.S. and Canada is that both the mean and relative variation of income is greater in the U.S. Consequently, crude techniques for measuring personal income variation will often bias estimates toward finding a steeper gradient in the U.S. 29 We utilize mainly JCUSH, which offers a better opportunity to measure both income and health status in each country in the same way and thus derive less biased estimates of the inter-country difference in the gradient. Some studies comparing gradients between countries have finessed the problem of noncomparable income distribution data by simply comparing the health status of individuals above and below the median income level (Decker and Remler, 2004) . In Table 13 we illustrate the bias in such an analysis applied to the U.S. and Canada. The gradient in the U.S. is steeper based on a comparison of the average health indicator for all those above the median with all those below the median. For example, in Canada, 14.7% of those below the median have poor or fair health compared to 4.9 % above the median-a 9.8 percentage point decline. In the US the corresponding decline is 11.8 percentage points. Similarly, the average percent reporting very good or excellent health rises by 18.8 percentage points in Canada and by 23.7 percentage points in the U.S. Source: JCUSH micro data (weighted means).
But the above and below the median comparisons are biased toward finding a steeper slope in the U.S. The source of the bias is shown when one uses the individual income data reported in JCUSH to compute the mean income of persons with incomes above and below the median. (The means of those above and below the median are displayed in the table.) Note that the ratio of mean income of those above the median to the mean income of those below median income is larger in the U.S. For all persons 18-64, the Canadian ratio is 3.16 and the U.S. ratio is 3.35. Thus the relative variance of income across persons is larger in the U.S., thereby generating a larger spread in the measures of health status even if the gradient were the same in both countries. By simply comparing those above and below the median in each country we are in effect imposing a steeper gradient on the U.S. data.
A better alternative is to measure the gradient with a continuous income variable that assigns a value to each individual. Thus the greater relative spread in the U.S. income data can be measured with some accuracy. The rate of change can be estimated as the partial regression coefficient of the income variable in separate multiple regression equations for Canada and the U.S. (using the health measure as the dependent variable) and the results for the two countries can be compared. The larger the coefficient (in absolute value), the steeper will be the gradient.
Following this approach we use the JCUSH data to conduct two analyses, one using the Health Utility Index (HUI) to measure health status and the other the self reported poor/fair measure of health. Table 14 shows the partial effect of income on the health utility index in multiple regression models that hold constant a number of other variables.
Income, as Cutler, Deaton and Lleras-Muney (2005) note, itself is likely to be affected by health. It is also correlated with other variables that affect health status such as education and health habits (smoking, obesity, physical fitness). We don't expect to resolve these difficult problems of cause and effect. We conduct the regression in two stages so that changes in the effect of income on health can be observed when different variables are included in the regression. Model I contains basic controls for demographic variables, education, smoking, weight and obesity levels, an index of physical activity represented here as a dichotomous variable indicating the lowest level of activity and interaction between the weight/obesity measures and the activity variable. Model II adds health access variables-unmet needs due to waiting, cost or other reasons, whether has a regular doctor and whether one lacks any form of health insurance -a variable relevant only for the U.S. Complete results for all the independent variables are given in the Appendix for the HUI regressions.
Among the 18-64 year olds included in the HUI regressions the gradient in both regression models is somewhat steeper in Canada than in the U.S. The addition of the health access measures in Model II reduces the income gradient coefficient slightly in both countries but the Canadian coefficient remains larger. The pattern of results is similar when we use the fair/poor measure of health status as the dependent variable. But for this measure of health status the Canadian coefficients are quite a bit steeper than those in the U.S.
Perhaps it should not be surprising to find that the gradient is at least as robust in Canada as in the U.S. despite the presence of a single payer system. It is difficult for any society to change individual behaviors that generate health risks and such behaviors are often strongly correlated with income. Nor does free access to medical care guarantee equal ability to navigate and use the health care system. Indeed, accounts show that wealthier and better-connected Canadians can "jump the queue" and gain quicker access to diagnostic tests and surgical treatment.
30
30 Brian Day, the president of the Canadian Medical Association revealed to the press his own use of connections to "jump the queue" to get a CT-scan for his daughter and for his own knee surgery. Dr. Day said he made the public revelation to both point out how widespread the practice of queue jumping is for the elite and to spur change in the system to reduce wait times. See the CanWest accounts (Baglo, 2007 and Jaimet, 2007) . 
CONSUMER SATISFACTION
The JCUSH asked two questions concerning consumer satisfaction, one dealing with how the respondent rates the quality of care received and the other with overall satisfaction with health care services received in the past year. Responses are given in Table 15 . U.S. respondents, quite significantly, gave higher ratings to the quality of care received and were more satisfied with health care services received than were the Canadians. Source: JCUSH micro data (weighted means).
CONCLUDING COMMENTS
It is often supposed that a publicly funded, single payer health care system, will deliver better health outcomes, and distribute health resources more fairly than a multi-payer system with a large private component. However, based on our analysis of health care measures in Canada and the U.S., we find that infant mortality and life expectancy-the two indicators most commonly used as evidence of better health outcomes in Canada-are poor measures of the relative effectiveness of the two health care systems because they are strongly influenced by cultural and behavioral factors that differ between the two countries such as the relatively high U.S. incidence of obesity and of accidents and homicides. Moreover, with respect to direct measures of the effectiveness of medical care, we find that five-year relative survival rates for those diagnosed with various types of cancer are higher in the U.S. than in Canada as are survival rates of high risk, low-birthweight infants.
As to the issue of inequality, Canada has no more abolished the tendency for health status to improve with income than have other countries. Indeed, using the JCUSH data on individual incomes and individual health status, we find that the health-income gradient is at least as prominent in Canada as it is in the U.S.
The need to ration when care is delivered "free" ultimately leads to long waits or to unavailable services and unmet needs. In the U.S. costs are more often a source of unmet needs. But costs may be more easily overcome than the absence of services. When asked about satisfaction with health services and the ranking of the quality of services recently received, more U.S. residents than Canadians respond that they are fully satisfied and rank quality of care as excellent.
One important issue that we do not address concerns the large differential in per capita health care expenditures, which are about twice as large in the U.S. as in Canada. Hints about the possible reasons for the difference in spending emerge in our review. The U.S. appears to have a population with a higher level of chronic conditions. The higher disease level may stem from unhealthy eating and exercise habits as evidenced by the higher rate of obesity. But despite those conditions, people in the U.S. report their health status as favorable.
Costly medical care may help explain the puzzle. Those in the U.S. who report chronic conditions report a greater likelihood of treatment than those with chronic conditions in Canada. The U.S. spends relatively more on screening and diagnostic testing and tends to approach treatment more aggressively and undoubtedly more expensively than Canada, as in the greater use of invasive treatment for cardiac patients. Do the additional expenditures buy additional benefits that justify greater expenditures? Alternatively, what would Canada have to spend to increase their technical capital and specialized medical personnel to match American levels, or to eliminate the longer waiting times? And would it be worthwhile for them to do so? These are complex but important questions for future research. 
